Somnolence

Somnolence is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as: Drowsiness · Sleepiness · Excessive Sleepiness · drowsiness or somnolence · drowsy
Classified under: Behavior And Behavior Mechanism
Disease and Non-Disease Concepts, Unclassified
Healthcare Systems and Public Health
Mental Disorders
Nervous System Diseases
Physiological and Biological Processes
Signs, Symptoms, and General Pathologies
Indicated drugs: Armodafinil
Caffeine

Resolves to

Vocabularies

MeSHM000640180ICD-10G47.1SNOMED CT139485005MedDRA10013649UMLSC0013144

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

38Clinical trialsPhase, status and sponsor resolved per trial

1Boxed warningLabel boxed warnings that name this condition

573Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Somnolence share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.